Ordering
Available Variants5 mg
CHA.52050-5mg
Price
€86.40
Available – Dispatch in 14 days
25 mg
CHA.52050-25mg
Price
€289.68
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.52050-5mg | €86.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.52050-25mg | €289.68 |
≥98% (HPLC), Wnt / β-catenin pathway inhibitor, powder
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C21H17N3O2S |
|---|---|
| CAS Number | 677331-12-3 |
| Molecular Weight | 375.44 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329825227 |
| NACRES | NA.77 |
| MDL number | MFCD04366833 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
iCRT14, also known by its CAS number 677331-12-3, is a potent and selective inhibitor of casein kinase 1 epsilon, an enzyme implicated in various cellular processes including the regulation of circadian rhythms. This compound has been utilized in research studies to investigate the role of casein kinase 1 epsilon in biological systems, providing valuable insights into its function and potential as a therapeutic target. The inhibition of casein kinase 1 epsilon by iCRT14 has been shown to affect the phosphorylation and activity of downstream targets, allowing researchers to dissect the complex signaling pathways regulated by this enzyme. As a result, iCRT14 has become a useful tool in the study of casein kinase 1 epsilon and its involvement in physiological and pathological processes, with potential applications in the development of novel therapeutic strategies. Its selective inhibition properties make it an attractive compound for further research.
